fda shortage glp-1 Hims: Is Tomorrow the End of the GLP-1 Shortage?

National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and

27.95

★★★★☆4.8 (126)

The FDA is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday

21.67

★★★★★4.9 (98)

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

20.86

★★★★★5.0 (157)

🚨 FDA UPDATE — April 1, 2026 (GLP-1 Compounding Just Changed), Most pharmacies haven’t realized what the latest FDA clarification actually means., On April 1, 2026, the U.S. Food and Drug

29.06

★★★★★4.7 (84)

FDA's GLP-1 decision kicks off 'unprecedented' tussle over shortage

22.09

★★★★★4.9 (203)

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over

22.96

★★★★★5.0 (176)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

23.43

★★★★★4.8 (132)